 BERKELEY HEIGHTS, N.J., March 22, 2022 GLOBE NEWSWIRE -- CorMedix Inc. Nasdaq: CRMD, a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2021, after the market close on Tuesday, March 29, 2022, and will host a corporate update conference call at 4:30pm Eastern Time. 